Worldwide Study Finder

Phase 4CompletedINTERVENTIONAL

Pharmacokinetics and Pharmacodynamics of Desmopressin Oral Lyophilisate Formulation in the Paediatric Population

ClinicalTrials.gov · NCT02584231 · Registry updated: 2019-02-06

Condition / research focus: Monosymptomatic Nocturnal Enuresis
Sponsor: University Ghent
Countries with listed sites: Belgium
Registry dates and results: Start: 2015-09-09. Completion: 2019-02-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

desmopressin (drug) — also listed as: dDAVP

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Ghent University Hospital - Department of Paediatric Nephrology
Ghent, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Influence of Food-intake on Desmopressin Oral Tablets and MELT-formulation

ClinicalTrials.gov · NCT01036841 · Registry updated: 2019-02-06

Condition / research focus: Enuresis; Polyuria
Sponsor: University Hospital, Ghent
Countries with listed sites: Belgium
Registry dates and results: Start: 2009-12. Completion: 2010-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

desmopressin tablet (drug)
desmopressin MELT formulation (drug)

Where the study takes place — 1 listed sites

University Hospital Ghent
Ghent, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Subjects

ClinicalTrials.gov · NCT03051009 · Registry updated: 2018-09-17

Condition / research focus: Nocturia
Sponsor: Ferring Pharmaceuticals
Countries with listed sites: Japan
Registry dates and results: Start: 2017-01-11. Completion: 2018-09-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin ODT 25 μg (drug) — also listed as: FE 992026
Desmopressin ODT 50 μg (drug) — also listed as: FE 992026

Where the study takes place — 1 listed sites

Investigational site (there may be other sites in this country)
Tokyo, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women

ClinicalTrials.gov · NCT01729819 · Registry updated: 2018-09-12

Condition / research focus: Overactive Bladder
Sponsor: Ferring Pharmaceuticals
Countries with listed sites: United States
Registry dates and results: Start: 2013-01. Completion: 2014-11 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tolterodine tartrate extended release capsules (drug)
Desmopressin orally disintegrating tablets (drug)
Placebo orally disintegrating tablets (drug)

Where the study takes place — 24 listed sites

NEA Baptist Clinic
Jonesboro, Arkansas, United States
Site recruitment: Not reported
Lynn Institute of The Ozarks
Little Rock, Arkansas, United States
Site recruitment: Not reported
Moez Khorsandi, DO
Los Angeles, California, United States
Site recruitment: Not reported
Urology Group of Southern California
Los Angeles, California, United States
Site recruitment: Not reported
Riverside Clinical Research
Edgewater, Florida, United States
Site recruitment: Not reported
Health Awareness, Inc.
Jupiter, Florida, United States
Site recruitment: Not reported
Pines Clinical Research, Inc.
Pembroke Pines, Florida, United States
Site recruitment: Not reported
Palm Beach Research Center
West Palm Beach, Florida, United States
Site recruitment: Not reported
Clinical Research Atlanta
Stockbridge, Georgia, United States
Site recruitment: Not reported
Northshore Center for Gastroenterology
Evanston, Illinois, United States
Site recruitment: Not reported
Remedica, LLC
Rochester, Michigan, United States
Site recruitment: Not reported
The Urological Institute of Northeastern New York
Albany, New York, United States
Site recruitment: Not reported
Premier Medical Group of the Hudson Valley, P.C.
Poughkeepsie, New York, United States
Site recruitment: Not reported
Parkhurst Research Organization, LLC
Bethany, Oklahoma, United States
Site recruitment: Not reported
Philadelphia Clinical Research, LLC
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported
Medical University of South Carolina
Charleston, South Carolina, United States
Site recruitment: Not reported
Coastal Carolina Research Center
Mt. Pleasant, South Carolina, United States
Site recruitment: Not reported
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Site recruitment: Not reported
Research Across America
Dallas, Texas, United States
Site recruitment: Not reported
Advances in Health
Houston, Texas, United States
Site recruitment: Not reported
Pioneer Research Solutions, Inc.
Houston, Texas, United States
Site recruitment: Not reported
Radiant Research
San Antonio, Texas, United States
Site recruitment: Not reported
Clinical Research Associates of Tidewater
Norfolk, Virginia, United States
Site recruitment: Not reported
Seattle Women's: Health, Research, Gynecology
Seattle, Washington, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers

ClinicalTrials.gov · NCT02506023 · Registry updated: 2018-07-16

Condition / research focus: Hemophilia A
Sponsor: Emory University
Countries with listed sites: United States
Registry dates and results: Start: 2015-07. Completion: 2018-06-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug) — also listed as: DDAVP

Where the study takes place — 2 listed sites

Children's Hospital of Atlanta Egleston
Atlanta, Georgia, United States
Site recruitment: Not reported
Emory University
Atlanta, Georgia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

A New Check-list Method for Nocturnal Enuresis

ClinicalTrials.gov · NCT03510975 · Registry updated: 2018-05-01

Condition / research focus: Nocturnal Enuresis
Sponsor: Ankara Training and Research Hospital
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2015-01-01. Completion: 2018-03-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

desmopressin melt form 120 μg (drug)
Verbal behavioral therapy (behavioral)
Behavioral therapy with written check-list (behavioral)

Where the study takes place — 1 listed sites

Ankara Training and Research Hospital
Ankara, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Platelets Antiaggregation Control Enhancement (PACE) Study

ClinicalTrials.gov · NCT01218074 · Registry updated: 2018-01-26

Condition / research focus: Bleeding; Blood Transfusion
Sponsor: Cardiochirurgia E.H.
Countries with listed sites: Italy
Registry dates and results: Start: 2010-12. Completion: 2017-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Aggregometry+Thromboelastography (device)
Thromboelastography Alone (device)

Where the study takes place — 1 listed sites

European Hospital
Rome, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

DDAVP vs. Exercise in Patients With Mild Hemophilia A

ClinicalTrials.gov · NCT03136003 · Registry updated: 2017-12-04

Condition / research focus: Mild Haemophilia A Without Inhibitor
Sponsor: The Hospital for Sick Children
Countries with listed sites: Canada
Registry dates and results: Start: 2017-07-04. Completion: 2018-08 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

DDAVP (drug) — also listed as: IN DDAVP, Octostim
Exercise (behavioral)

Where the study takes place — 2 listed sites

St. Michael's Hospital
Toronto, Ontario, Canada
Site recruitment: Not yet recruiting
The Hospital for Sick Children
Toronto, Ontario, Canada
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Effects of Prophylactic Desmopressin on Blood Coagulation Parameters in Heart Valve Surgery

ClinicalTrials.gov · NCT03343418 · Registry updated: 2017-11-17

Condition / research focus: C.Surgical Procedure; Cardiac; Blood Coagulation Disorders
Sponsor: Instituto do Coracao
Countries with listed sites: Brazil
Registry dates and results: Start: 2015-02. Completion: 2017-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Incor - Heart Institute - University of Sao Paulo
São Paulo, Brazil
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Treatment of Supine Hypertension in Autonomic Failure

ClinicalTrials.gov · NCT00223717 · Registry updated: 2017-10-13

Condition / research focus: Hypertension
Sponsor: Vanderbilt University
Countries with listed sites: United States
Registry dates and results: Start: 2001-01. Completion: 2017-01 (may be estimated). No results posted in this registry response.

Products and interventions (24)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Clonidine (drug) — also listed as: Catapres
Nitroglycerin transdermal (drug) — also listed as: Nitro-Dur
Dipyridamole/ Aspirin (Aggrenox) (drug) — also listed as: Aggrenox
Desmopressin (DDAVP) (drug) — also listed as: DDAVP
Sildenafil (drug) — also listed as: Viagra
Nifedipine (drug) — also listed as: Adalat
Hydralazine (drug)
Hydrochlorothiazide (drug) — also listed as: Microzide
Placebo (drug)
Bosentan (drug) — also listed as: Tracleer
Diltiazem (drug) — also listed as: Cardizem
Eplerenone (drug) — also listed as: Inspra
guanfacine (drug) — also listed as: Tenex
L-arginine (dietary_supplement)
captopril (drug) — also listed as: capoten
carbidopa (drug) — also listed as: Lodosyn
losartan (drug) — also listed as: cozaar
metoprolol tartrate (drug) — also listed as: lopressor
nebivolol hydrochloride (drug) — also listed as: Bystolic
prazosin hydrochloride (drug) — also listed as: Minipress
tamsulosin hydrochloride (drug) — also listed as: Flomax
Head-up tilt. (other) — also listed as: HUT
aliskiren (drug) — also listed as: Tekturna
Local heat stress (other) — also listed as: heating pad

Where the study takes place — 1 listed sites

Vanderbilt University
Nashville, Tennessee, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal Bleeding

ClinicalTrials.gov · NCT01623206 · Registry updated: 2017-08-24

Condition / research focus: Colorectal Cancer; Rectal Bleeding
Sponsor: Laboratorio Elea Phoenix S.A.
Countries with listed sites: Argentina
Registry dates and results: Start: 2013-04. Completion: 2017-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug)

Where the study takes place — 2 listed sites

Hospital de Gastroenterologia ¨B.Udaondo¨
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Site recruitment: Not reported
Instituto de Oncología "Alexander Fleming"
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary

ClinicalTrials.gov · NCT01552343 · Registry updated: 2017-07-11

Condition / research focus: Nocturia
Sponsor: Ferring Pharmaceuticals
Countries with listed sites: United States
Registry dates and results: Start: 2012-03. Completion: 2012-06 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug) — also listed as: FE992026, MINIRIN®, Nocturin®
Placebo (drug)

Where the study takes place — 10 listed sites

South Florida Medical Research
Aventura, Florida, United States
Site recruitment: Not reported
Avail Clinical Research, LLC
DeLand, Florida, United States
Site recruitment: Not reported
Accelovance
Peoria, Illinois, United States
Site recruitment: Not reported
DM Clinical Research
Springfield, Massachusetts, United States
Site recruitment: Not reported
Beyer Research
Kalamazoo, Michigan, United States
Site recruitment: Not reported
Remedica LLC
Rochester, Michigan, United States
Site recruitment: Not reported
Accumed Research Associates
Garden City, New York, United States
Site recruitment: Not reported
Radiant Research, Inc.
Greer, South Carolina, United States
Site recruitment: Not reported
Quality Research, Inc.
San Antonio, Texas, United States
Site recruitment: Not reported
Radiant Research, Inc.
San Antonio, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Effects of Desmopressin on Blood Loss and the Quality of the Surgical Field During Endoscopic Sinus Surgery

ClinicalTrials.gov · NCT02125188 · Registry updated: 2017-06-06

Condition / research focus: Patients Undergoing Endoscopic Sinus Surgery
Sponsor: Tao Zhang
Countries with listed sites: China
Registry dates and results: Start: 2014-01. Completion: 2014-08 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug)
saline (drug)

Where the study takes place — 1 listed sites

First Affiliated Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Documentation of the Efficacy of Desmopressin Within the Context of Surgical Procedures

ClinicalTrials.gov · NCT02368730 · Registry updated: 2017-06-02

Condition / research focus: Platelet Dysfunction
Sponsor: Ferring Pharmaceuticals
Countries with listed sites: Germany
Registry dates and results: Start: 2015-06. Completion: 2016-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

desmopressin (drug) — also listed as: Minirin

Where the study takes place — 1 listed sites

Charité - Universitätsmedizin Berlin (there may be other sites in this country)
Berlin, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressin in Valve-Replacement Surgery

ClinicalTrials.gov · NCT01994330 · Registry updated: 2017-04-05

Condition / research focus: Acquired Von Willebrand Disease Secondary to Severe Aortic Stenosis; Heye´s Syndrome; Severe Aortic Stenosis
Sponsor: Pontificia Universidad Catolica de Chile
Countries with listed sites: Chile
Registry dates and results: Start: 2009-06. Completion: 2010-02 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

desmopressin (drug) — also listed as: DDAVP

Where the study takes place — 1 listed sites

Hospital Clínico Universidad Católica de Chile
Santiago, Santiago Metropolitan, Chile
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3TerminatedINTERVENTIONAL

Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older

ClinicalTrials.gov · NCT02262936 · Registry updated: 2016-11-15

Condition / research focus: Nocturia
Sponsor: Mount Sinai Hospital, Canada
Countries with listed sites: Canada
Registry dates and results: Start: 2015-07. Completion: 2016-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug)
Fesoterodine (drug)

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Intranasal Desmopressin vs IV Ketorolac in Renal Colic Pain Control

ClinicalTrials.gov · NCT02937896 · Registry updated: 2016-10-19

Condition / research focus: Renal Colic
Sponsor: Shahid Beheshti University of Medical Sciences
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-01. Completion: 2016-04 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug) — also listed as: Ddavp
Ketorolac (drug) — also listed as: Toradol
Normal Saline (drug) — also listed as: NaCl
Normal Saline (drug) — also listed as: NaCl

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Effects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE Study

ClinicalTrials.gov · NCT02729766 · Registry updated: 2016-08-10

Condition / research focus: Inappropriate ADH Syndrome
Sponsor: University Hospital, Basel, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 2016-03. Completion: 2016-08 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Induced hypotonic hyponatremia - SIAD model (other) — also listed as: Induced hypotonic hyponatremia
Empagliflozin 25mg Tbl (drug)
Placebo P-Tablet (drug)

Where the study takes place — 1 listed sites

Department Endocrinology University Hospital Basel
Basel, Basel, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia

ClinicalTrials.gov · NCT01552395 · Registry updated: 2016-05-24

Condition / research focus: Nocturia
Sponsor: Ferring Pharmaceuticals
Countries with listed sites: Czechia
Registry dates and results: Start: 2012-03. Completion: 2016-04 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 68 listed sites

Nemocnice Rudolfa a Stefanie (there may be other sites in this country)
Benešov, Czechia
Site recruitment: Not reported
Soukromá ambulance, Benešov
Benešov, Czechia
Site recruitment: Not reported
Soukromá ambulance Beroun
Beroun, Czechia
Site recruitment: Not reported
Slezská urologie
Bohunín, Czechia
Site recruitment: Not reported
URIONTEGRITAS soukromá ambulance
Brno, Czechia
Site recruitment: Not reported
Uro - clinic
Brno, Czechia
Site recruitment: Not reported
Urocentrum Brno
Brno, Czechia
Site recruitment: Not reported
Úrazová nemocnice Brno
Brno, Czechia
Site recruitment: Not reported
Soukromá ambalance
Citonice, Czechia
Site recruitment: Not reported
Domažlická Nemocnice
Domažlice, Czechia
Site recruitment: Not reported
Městská nemocnice Dvůr Králové nad Labem a.s.
Dvůr Králové nad Labem, Czechia
Site recruitment: Not reported
Nemocnice s poliklinkou Havířov
Havířov, Czechia
Site recruitment: Not reported
Nemocnice Havlíčkův Brod
Havlíčkův Brod, Czechia
Site recruitment: Not reported
Gynekologická ambulance Hluk
Hluk, Czechia
Site recruitment: Not reported
Fakultní nemocnice Hradec Králové
Hradec Králové, Czechia
Site recruitment: Not reported
PPCHC Sanus Hradec Králové
Hradec Králové, Czechia
Site recruitment: Not reported
Městská nemocnice Hustopeče
Hustopeče U Brna, Czechia
Site recruitment: Not reported
Urologická ambulance UROLA
Jaroměř, Czechia
Site recruitment: Not reported
Soukromá ambulance, Jilemnice
Jilemnice, Czechia
Site recruitment: Not reported
Oblastní nemocnice Kladno a.s.
Kladno, Czechia
Site recruitment: Not reported
Urologie s.r.o.
Klatovy, Czechia
Site recruitment: Not reported
Soukromá ambulance Krnov
Krnov, Czechia
Site recruitment: Not reported
Kromerizska nemocnice a.s.
Kroměříž, Czechia
Site recruitment: Not reported
Soukromá ambulance, Lanškroun
Lanškroun, Czechia
Site recruitment: Not reported
Soukromá ambulance Mohelnice
Mohelnice, Czechia
Site recruitment: Not reported
Oblastní nemocnice Náchod
Náchod, Czechia
Site recruitment: Not reported
Sourkomá ambulance, Nový Jičín
Nový Jičín, Czechia
Site recruitment: Not reported
Nemocnice Nový Jičín
Nový Jíčín, Czechia
Site recruitment: Not reported
Centrum MEDIOL s.r.o.
Olomouc, Czechia
Site recruitment: Not reported
FN Olomouc
Olomouc, Czechia
Site recruitment: Not reported
Městská nemocnice Ostrava
Ostrava, Czechia
Site recruitment: Not reported
Gynekologická ambulance
Ostrava Ploskovice, Czechia
Site recruitment: Not reported
Vítkovická Nemocnice a.s.
Ostrava-Vítkovice, Czechia
Site recruitment: Not reported
Nemocnice Pelhřimov
Pelhřimov, Czechia
Site recruitment: Not reported
FN Plzeň
Pilsen, Czechia
Site recruitment: Not reported
Poliklinika Denisovo nábřeží
Pilsen, Czechia
Site recruitment: Not reported
Nemocnice Písek
Písek, Czechia
Site recruitment: Not reported
Urologická ambulance
Prachatice, Czechia
Site recruitment: Not reported
FN Bulovka
Prague, Czechia
Site recruitment: Not reported
Medicon
Prague, Czechia
Site recruitment: Not reported
Nemocnice s poliklinikou Praha Italská
Prague, Czechia
Site recruitment: Not reported
Soukromá ambulance Praha 7
Prague, Czechia
Site recruitment: Not reported
Soukromá ambulance, Praha 5
Prague, Czechia
Site recruitment: Not reported
Urocare
Prague, Czechia
Site recruitment: Not reported
Urologická klinika Praha 1
Prague, Czechia
Site recruitment: Not reported
Urologické oddělení
Prague, Czechia
Site recruitment: Not reported
Urologie Zahradní Město s.r.o.
Prague, Czechia
Site recruitment: Not reported
Urosanté s.r.o
Prague, Czechia
Site recruitment: Not reported
VFN
Prague, Czechia
Site recruitment: Not reported
Ústřední vojenská nemocnice
Prague, Czechia
Site recruitment: Not reported
Urologie - NZZ Lékařský dům
Praha 10 - Uhříněves, Czechia
Site recruitment: Not reported
JR Urocentrum Přerov s.r.o.
Přerov, Czechia
Site recruitment: Not reported
Soukromá ambulance, Přeštice
Přeštice, Czechia
Site recruitment: Not reported
Urocare s.r.o.
Říčany, Czechia
Site recruitment: Not reported
Soukromá ambulance Štemberk
Štemberk, Czechia
Site recruitment: Not reported
Nemocnice Tábor
Tábor, Czechia
Site recruitment: Not reported
Krajská zdravotní - nemocnice Teplice
Teplice, Czechia
Site recruitment: Not reported
Urologická ambulance
Trutnov, Czechia
Site recruitment: Not reported
Nemocnice Třebíč
Třebíč, Czechia
Site recruitment: Not reported
Nemocnice Podlesí a.s.
Třinec, Czechia
Site recruitment: Not reported
Městská nemocnice Turnov
Turnov, Czechia
Site recruitment: Not reported
Nemocnice Uherské Hradiště
Uherské Hradiště, Czechia
Site recruitment: Not reported
Masarykova nemocnice v Ústí nad Labem
Ústí nad Labem, Czechia
Site recruitment: Not reported
Nemocnice Valašské Meziříčí
Valašské Meziříčí, Czechia
Site recruitment: Not reported
DUAM s.r.o. Lékařský dům
Zlín, Czechia
Site recruitment: Not reported
Krajská nemocnice T.Bati a.s.
Zlín, Czechia
Site recruitment: Not reported
Soukromá ambulance, Zlín
Zlín, Czechia
Site recruitment: Not reported
UROKAN s.r.o.
Znojmo, Czechia
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

V2 Receptor Effects on Fluid Regulation and Performance

ClinicalTrials.gov · NCT02084797 · Registry updated: 2016-05-12

Condition / research focus: Electrolyte Imbalance; Hyponatremia; Hypernatremia
Sponsor: Oakland University
Countries with listed sites: United States
Registry dates and results: Start: 2011-06. Completion: 2012-10 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

V2R (Vasopressin 2 receptor) (drug) — also listed as: V2R antagonist: tolvaptan (30mg tablet), V2R agonist: desmopressin (0.2mg tablet)

Where the study takes place — 1 listed sites

Oakland University
Rochester, Michigan, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Worldwide Study Finder

Find a study

Registry search results

Pharmacokinetics and Pharmacodynamics of Desmopressin Oral Lyophilisate Formulation in the Paediatric Population

Explore the world’s study registries

Worldwide

Africa

Americas

Influence of Food-intake on Desmopressin Oral Tablets and MELT-formulation

Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Subjects

Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women

Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers

A New Check-list Method for Nocturnal Enuresis

Platelets Antiaggregation Control Enhancement (PACE) Study

DDAVP vs. Exercise in Patients With Mild Hemophilia A

Effects of Prophylactic Desmopressin on Blood Coagulation Parameters in Heart Valve Surgery

Treatment of Supine Hypertension in Autonomic Failure

Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal Bleeding

Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary

Effects of Desmopressin on Blood Loss and the Quality of the Surgical Field During Endoscopic Sinus Surgery

Documentation of the Efficacy of Desmopressin Within the Context of Surgical Procedures

Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressin in Valve-Replacement Surgery

Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older

Intranasal Desmopressin vs IV Ketorolac in Renal Colic Pain Control

Effects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE Study

A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia

V2 Receptor Effects on Fluid Regulation and Performance

Asia

Middle East

Europe

Oceania